Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase (BA/BE Studies, Phase I, Phase II), Sector (Clinical Trial Logistics and Distributions, Clinical Trial Manufacturing Services, Clinical Trial Supply Chain Management), Therapeutic Area -

Clinical Trial Supply & Logistics for Pharmaceutical Market by Phase (BA/BE Studies, Phase I, Phase II), Sector (Clinical Trial Logistics and Distributions, Clinical Trial Manufacturing Services, Clinical Trial Supply Chain Management), Therapeutic Area - Global Forecast 2024-2030

The Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 22.73 billion in 2023 and expected to reach USD 24.48 billion in 2024, at a CAGR 7.75% to reach USD 38.34 billion by 2030.

The clinical trial supply chain is a critical aspect of the pharmaceutical industry, as it involves the storage, distribution, and monitoring of investigational medicinal products (IMPs) used in clinical studies. Clinical trial logistics primarily aim to ensure that the essential resources are available at the right time, place, and under optimal conditions to maintain quality throughout the trial process. Clinical trial supply & logistics plays a vital role in the overall success of drug development programs by directly impacting cost management, risk mitigation, efficiency improvement, and patient safety. Some major trends contributing to this industry growth include the globalization of clinical trials, the adoption of technology-driven solutions, and the outsourcing of non-core functions within pharmaceutical companies. The growth of the clinical trial supply & logistics (CTSL) market has been significantly influenced by the increasing Research and Development (R&D) expenditure in the pharmaceutical sector. Pharmaceutical R&D is vital in developing innovative drugs and therapies that improve healthcare outcomes worldwide. The continuous expansion in R&D investments has propelled advancements in clinical trial processes, leading to robust growth in the clinical trial supply & logistics industry. The pharmaceutical industry has faced significant challenges due to the escalating drug development costs and clinical trials. These increased expenses have substantially impacted various aspects of the industry, leading to reduced investment by pharmaceutical companies in their clinical trial supply chain management systems. In recent years, the pharmaceutical industry substantially increased in outsourcing clinical trial activities to contract research organizations (CROs) and other third-party service providers. Multiple factors drive this trend, including the need for cost reduction, access to specialized expertise, and the demand for faster drug development processes, which has significantly supplemented growth in the clinical trial supply chain and logistics services.

Regional Insights

Americas has endured a significant position in the pharmaceutical market's clinical trial supply & logistics due to the adoption of technologically advanced products, well-established regulatory agencies, and considerable contract research organizations. The United States is increasingly focusing on generics and biologics, both cost-effective alternatives to traditional pharmaceuticals. The market has witnessed an increase in business growth with rising demand for generic prescription drugs that the FDA has approved to be the equivalent of a brand-name drug in dosage, safety, strength, quality, performance, and intended use. Asia-Pacific's expanding technology sector and enhancement in the pharmaceutical services in emerging countries such as China, Korea, and India create several growth opportunities for supply chain management solutions. In contrast, countries such as Australia, Japan, and Singapore represent the developed healthcare systems in the region. EMEA clinical trial supply & logistics for the pharmaceutical market has focused on the re-oriented healthcare and pharmaceutical systems to ensure efficient service delivery. The European region represents the developed market, closely following the developed market's technological and healthcare development trends. The European Union (EU) plays a significant role in the pharmaceutical industry and is a substantial trader in pharmaceuticals and medicinal products. Manufacturing and distribution have also become increasingly globalized, with the maintenance of supply & logistics integrity becoming a high priority for ensuring the safety and quality of drugs and devices, increasing demand for next-generation clinical trial supply & logistics.

Market Insights

• Market Dynamics
  
  The market dynamics represent an ever-changing landscape of the Clinical Trial Supply & Logistics for Pharmaceutical Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing R&D Expenditure of Pharmaceutical and Biopharmaceutical Industry
    • Increased Focus on Drug Development
    • Globalization of Clinical Trials and Harmonization of Regulations
    • Market Restraints
      • Increased Cost of Drug Development and Clinical Trials
      • Market Opportunities
        • Outsourcing of Clinical Trial Activity
        • Increased Focus on Generics and Biologics
        • Regulatory Approvals in Emerging Markets
        • Market Challenges
          • Logistics Challenges Across Nations
          • Market Segmentation Analysis
            • Phase: Rising inclination toward Phase III trials owing to the need for exponential utility of clinical trial supply & logistics
            • Therapeutic Area: Exponential utility of clinical trial supply & logistics to cater to the ever-growing oncology R&D activities
            • Market Disruption Analysis
            • Porter’s Five Forces Analysis
            • Value Chain & Critical Path Analysis
            • Pricing Analysis
            • Technology Analysis
            • Patent Analysis
            • Trade Analysis
            • Regulatory Framework Analysis
            FPNV Positioning Matrix
            
            The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Trial Supply & Logistics for Pharmaceutical Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
            
            Market Share Analysis
            
            The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Trial Supply & Logistics for Pharmaceutical Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
            
            Recent Developments
            • Ariceum Therapeutics and Eurofins CDMO Sign a Pharmaceutical Multi-Project Agreement
              
              Ariceum Therapeutics has entered into an agreement with Eurofins CDMO, a leading global Contract Development and Manufacturing Organization, to provide Clinical Trial Supply services.Eurofins CDMO provides various services to Ariceum, including Qualified Person (QP) release of drug substance in Europe, drug substance storage, drug product packaging, cold chain management, and drug product deliveries to investigational sites.
              
              Catalent Completes Expansion of Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
              
              Catalent, Inc., the provider of clinical trial supply and logistics solutions for the pharmaceutical industry, recently completed a significant expansion to its clinical supply facility in Singapore. With an investment of USD 2.2 million, the facility spans an impressive 31,000 square feet. This expansion includes adding 35 new freezers for ultra-low temperature (ULT) storage and specialized secondary packaging capabilities.
              
              Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
              
              Parexel recently inaugurated a state-of-the-art clinical trial supply and logistics depot in Suzhou, China. This strategically positioned facility offers local and international biopharmaceutical clients conducting clinical trials in the region prompt access to essential supplies and investigational treatments for global distribution. Equipped with temperature-controlled storage capabilities (-20ºC, 2-8ºC, 15-25ºC, -80ºC), the depot is equipped to handle secondary packaging/labeling, fulfillment/distribution, and drug sourcing, among other services.
            Strategy Analysis & Recommendation
            
            The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Trial Supply & Logistics for Pharmaceutical Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
            
            Key Company Profiles
            
            The report delves into recent significant developments in the Clinical Trial Supply & Logistics for Pharmaceutical Market, highlighting leading vendors and their innovative profiles. These include Almac Group, AmerisourceBergen Corporation, Bilcare Limited, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, DHL International GmbH by Deutsche Post AG, Eurofins Scientific SE, FedEx Corporation, ICON PLC, Infosys Limited, KLIFO A/S, Lonza Group, Marken, Movianto, N-Side, Parexel International Corporation, PCI Pharma Services, Seveillar Clinical Trial Supplies Pvt. Ltd., SIRO Clinpharm Private Limited, and Thermo Fisher Scientific, Inc..
            
            Market Segmentation & Coverage
            
            This research report categorizes the Clinical Trial Supply & Logistics for Pharmaceutical Market to forecast the revenues and analyze trends in each of the following sub-markets:
            • Phase
              • BA/BE Studies
              • Phase I
              • Phase II
              • Phase III
              • Phase IV
              • Sector
                • Clinical Trial Logistics and Distributions
                • Clinical Trial Manufacturing Services
                • Clinical Trial Supply Chain Management
                • Therapeutic Area
                  • Blood Disorders
                  • Digestive System Diseases
                  • Infectious and Immune System Diseases
                  • Neurological and Mental Disorders
                  • Oncology
                  • Region
                    • Americas
                      • Argentina
                      • Brazil
                      • Canada
                      • Mexico
                      • United States
                        • California
                        • Florida
                        • Illinois
                        • New York
                        • Ohio
                        • Pennsylvania
                        • Texas
                        • Asia-Pacific
                          • Australia
                          • China
                          • India
                          • Indonesia
                          • Japan
                          • Malaysia
                          • Philippines
                          • Singapore
                          • South Korea
                          • Taiwan
                          • Thailand
                          • Vietnam
                          • Europe, Middle East & Africa
                            • Denmark
                            • Egypt
                            • Finland
                            • France
                            • Germany
                            • Israel
                            • Italy
                            • Netherlands
                            • Nigeria
                            • Norway
                            • Poland
                            • Qatar
                            • Russia
                            • Saudi Arabia
                            • South Africa
                            • Spain
                            • Sweden
                            • Switzerland
                            • Turkey
                            • United Arab Emirates
                            • United Kingdom
                            
                            
                            Please Note: PDF & Excel + Online Access - 1 Year